S
Susanne K. Kjaer
Researcher at University of Copenhagen
Publications - 674
Citations - 41997
Susanne K. Kjaer is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 90, co-authored 636 publications receiving 36979 citations. Previous affiliations of Susanne K. Kjaer include Copenhagen University Hospital & McGill University.
Papers
More filters
Journal ArticleDOI
Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS/LSIL, HSIL, or cervical cancer: what is the potential for prevention?
TL;DR: The particular carcinogenic role of HPV16 and 18 is confirmed and may support a role of genotyping for HPV 16 and 18 in cervical cancer screening.
Journal ArticleDOI
Fertility treatment and childhood cancer risk: a systematic meta-analysis.
TL;DR: The results of the largest meta-analysis on this topic to date indicate an association between fertility treatment and cancer in offspring, however, this results do not rule out that factors related to underlying subfertility, rather than the procedure itself, are the most important predisposing factors for childhood cancer.
Journal ArticleDOI
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D
Xin Yang,Honglin Song,Goska Leslie,Christoph Engel,Eric Hahnen,Bernd Auber,Judit Horvath,Karin Kast,Karin Kast,Karin Kast,Dieter Niederacher,Clare Turnbull,Richard S. Houlston,Helen Hanson,Chey Loveday,Jill S. Dolinsky,Holly LaDuca,Susan J. Ramus,Susan J. Ramus,Usha Menon,Adam N. Rosenthal,Ian Jacobs,Ian Jacobs,Ian Jacobs,Simon A. Gayther,Ed Dicks,Heli Nevanlinna,Kristiina Aittomäki,Liisa M. Pelttari,Hans Ehrencrona,Åke Borg,Anders Kvist,Barbara Rivera,Thomas Hansen,Malene Djursby,Andy C. H. Lee,Joe Dennis,David D.L. Bowtell,David D.L. Bowtell,Nadia Traficante,Nadia Traficante,Orland Diez,Judith Balmaña,Stephen B. Gruber,Georgia Chenevix-Trench,kConFab Investigators,Allan Jensen,Susanne K. Kjaer,Estrid Høgdall,Laurent Castera,Judy Garber,Ramunas Janavicius,Ana Osorio,Lisa Golmard,Ana Vega,Fergus J. Couch,Mark E. Robson,Jacek Gronwald,Susan M. Domchek,Julie O. Culver,Miguel de la Hoya,Douglas F. Easton,W. D. Foulkes,W. D. Foulkes,Marc Tischkowitz,Marc Tischkowitz,Alfons Meindl,Rita K. Schmutzler,Paul D.P. Pharoah,Antonis C. Antoniou +69 more
TL;DR: Both TOC and BC risks for RAD51C and RAD51D pathogenic variant carriers varied by cancer family history and could be as high as 32–36% for TOC, for carriers with two first-degree relatives diagnosed with Toc, or 44–46% for BC, for carrier with two second-degree relative diagnosed with BC.
Journal ArticleDOI
Crohn's disease and cancer risk (Denmark).
Lene Mellemkjær,Christoffer Johansen,Gloria Gridley,Martha S. Linet,Susanne K. Kjaer,Jørgen H. Olsen +5 more
TL;DR: Only for small intestinal cancer was a significantly elevated risk found among these patients hospitalized with Crohn's disease, and it was not detectable in the overall risk estimate for colorectal cancer.
Journal ArticleDOI
High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival.
Estrid Høgdall,Julia S. Johansen,Susanne K. Kjaer,Paul A. Price,Lise Christensen,Jan Blaakær,Johannes E. Bock,Eva Glud,Claus Høgdall +8 more
TL;DR: Plasma levels of YKL-40 proved of prognostic value in stage III OC patients and was highest in the patients who died during the follow-up compared to the patients still alive.